Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Current Liabilities (2016 - 2017)

Tenax Therapeutics' Total Current Liabilities history spans 6 years, with the latest figure at $838552.0 for Q3 2017.

  • For Q3 2017, Total Current Liabilities fell 83.42% year-over-year to $838552.0; the TTM value through Sep 2017 reached $838552.0, down 83.42%, while the annual FY2016 figure was $6.2 million, N/A changed from the prior year.
  • Total Current Liabilities for Q3 2017 was $838552.0 at Tenax Therapeutics, down from $2.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.2 million in Q4 2016 and bottomed at $838552.0 in Q3 2017.
  • The 4-year median for Total Current Liabilities is $4.8 million (2015), against an average of $3.9 million.
  • The largest annual shift saw Total Current Liabilities surged 34.72% in 2016 before it tumbled 83.42% in 2017.
  • A 4-year view of Total Current Liabilities shows it stood at $2.0 million in 2013, then skyrocketed by 131.04% to $4.6 million in 2015, then soared by 34.72% to $6.2 million in 2016, then plummeted by 86.47% to $838552.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Total Current Liabilities are $838552.0 (Q3 2017), $2.2 million (Q2 2017), and $5.0 million (Q1 2017).